SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-22-073970
Filing Date
2022-06-23
Accepted
2022-06-23 18:00:26
Documents
1
Period of Report
2022-04-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2219110-1_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2219110-1_4aseq1.xml 4/A 4446
  Complete submission text file 0001104659-22-073970.txt   5912
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Issuer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE, 12TH FLOOR NEW YORK NY 10017
Business Address
Bernstein Bruce (Reporting) CIK: 0001665472 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40458 | Film No.: 221036518